Dr Liz Roundhill
- Position
- Post-doctoral researcher
- Areas of expertise
- Ewing sarcoma, bone sarcomas, patient-derived cell cultures, 3D spheroids and multi-cellular models, High-content imaging
- [email protected]
- Phone
- 01133438448
- Location
- WTBB, SJUH
- Faculty
- Faculty of Medicine and Health
- School
- School of Medicine
- Faculty profile link
- https://medicinehealth.leeds.ac.uk/medicine/staff/2999/dr-elizabeth-roundhill
My work is using patient-derived models to identify novel targets and biomarkers to improve outcomes for patients with Ewing sarcoma.
Roundhill EA, Pantziarka P, Liddle DE, Shaw LA, Albadrani G, Burchill SA. 2023. Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. Cancers. 15.3
Brookes MJ, Roundhill EA, Jeys L, Parry M, Burchill SA, Rankin KS. 2022. Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma. Pediatric Blood & Cancer. 69.12
Roundhill EA, Chicon-Bosch M, Jeys L, Parry M, Rankin KS, Droop A, Burchill SA. 2021. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma. Cellular Oncology. 1065-1085 44.5